Physician profile
Jordan B Simpson
NPI 1104143957
$9,281.26
in general payments reported to CMS, 2019-2025
17 companies · $279 in 2025
The $279 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $292 · 2020: $322 · 2021: $3,706 · 2022: $3,003 · 2023: $997 · 2024: $682 · 2025: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,958.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,957.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $7,618.80 | 2019-2025 | Mako, Aequalis Perform Reversed, Aequalis Perform+ |
| Medical Device Business Services, INC. | $601.78 | 2021 | |
| Bioventus LLC | $316.20 | 2019-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System, Bioness Integrated System (Bits)2.0.5 |
| Depuy Synthes Sales INC. | $295.47 | 2019-2024 | Monovisc |
| Zimmer Biomet Holdings, INC. | $130.86 | 2022 | |
| Exactech, INC. | $91.29 | 2019 | |
| Baxter Healthcare | $32.35 | 2024 | Floseal |
| Abbott Laboratories | $30.50 | 2024 | Proclaim |
| Ferring Pharmaceuticals INC. | $25.64 | 2025 | Euflexxa |
| Innovation Technologies INC | $21.65 | 2024 | Irrisept |
| Pacira Pharmaceuticals Incorporated | $21.06 | 2025 | Exparel |
| Smith+Nephew, INC. | $19.35 | 2024 | Stravix |
| Orthofix Medical, INC. | $16.54 | 2024 | Physio-Stim |
| Merck Sharp & Dohme LLC | $16.19 | 2025 | Bridion |
| Integra Lifesciences Corporation | $15.20 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $14.24 | 2021 | |
| Amgen INC. | $14.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Simpson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.